Kuten A, Rosenblatt E, Dale J, Leviov M, Tatcher M
Radiotherapy Unit, Northern Israel Oncology Center, Rambam Hospital, Haifa.
Leuk Lymphoma. 1993 Jul;10(4-5):281-5. doi: 10.3109/10428199309148550.
The rare, indolent, but lethal malignancy, mycosis fungoides (MF), is amenable to durable remissions if treated topically at an early stage with nitrogen mustard, PUVA, or radiotherapy. A modification of conventional therapeutic irradiation which utilizes electron beams rather than photons, has been in use since 1951. This method, termed total skin electron irradiation (TSEI), has achieved consistently good CR rates (95-100%) at a variety of centres in the U.S.A., England, France, and Italy, despite troublesome differences in staging systems. In northern Israel we have treated 37 MF patients with TSEI during the past 13 years. All 21 of our early stage patients achieved CR, which is no longer regarded as an unusual result. However, most workers in the field acknowledge that issues of optimal dosing and curative potency remain unresolved.
蕈样肉芽肿(MF)是一种罕见、进展缓慢但致命的恶性肿瘤,如果在早期使用氮芥、补骨脂素紫外线A光化学疗法(PUVA)或放射疗法进行局部治疗,是可以实现持久缓解的。自1951年以来,一直在使用一种改良的传统治疗性照射方法,该方法使用电子束而非光子。这种方法称为全身皮肤电子照射(TSEI),在美国、英国、法国和意大利的多个中心一直取得了良好的完全缓解(CR)率(95 - 100%),尽管分期系统存在麻烦的差异。在以色列北部,我们在过去13年中用TSEI治疗了37例MF患者。我们所有21例早期患者都实现了CR,这已不再被视为异常结果。然而,该领域的大多数工作者都承认,最佳剂量和治愈效力的问题仍未得到解决。